German Court Upholds Cancellation of CeramTec's Pink Trademark, Bolstering CoorsTek's Competitive Position

The German Federal Patent Court's ruling that CeramTec's pink trademark was filed in bad faith removes a key barrier for CoorsTek Bioceramics, potentially reshaping competition in the orthopaedic ceramics market.

DC Metrowire Staff
••Business
German Court Upholds Cancellation of CeramTec's Pink Trademark, Bolstering CoorsTek's Competitive Position

The German Federal Patent Court (GFPC) has upheld the cancellation of CeramTec GmbH's trademark on the color pink for ceramic hip components, marking a significant legal victory for CoorsTek Bioceramics in their ongoing dispute. The court found that CeramTec's trademark application was filed in bad faith, intended to extend an expiring patent monopoly and block competitors from the market. This decision is crucial because it removes a contentious barrier to competition, allowing CoorsTek to more freely market its ceramic hip replacement components, including its Permallon orthopaedic ceramics line.

The ruling has broader implications for the orthopaedic ceramics supply chain. It follows similar favorable decisions for CoorsTek in France and the United States, suggesting a consistent legal trend against CeramTec's trademark strategy. By invalidating the pink trademark in Germany, the court has effectively reinforced the principle that trademark law should not be used to perpetuate patent monopolies. This could encourage other manufacturers to enter the market, potentially leading to increased innovation and lower prices for medical devices. For CoorsTek, the decision is a strategic win that enhances its ability to compete in a critical European market. The company has emphasized that this ruling, combined with other court wins and OEM regulatory clearances, is building a more competitive orthopaedic ceramics supply chain. For full details, click here.

CeramTec has appealed the decision, so the legal battle may continue. However, the GFPC's ruling sends a strong signal that trademark applications filed with the intent to hinder competition will not be tolerated. This development is important not only for the companies involved but also for the broader medical device industry, as it clarifies the boundaries between patent and trademark rights. CoorsTek Bioceramics, a subsidiary of CoorsTek, has a long history in technical ceramics and has sold over six million components for clinical use since 2005. The ruling supports its position as a key player in the orthopaedic ceramics market and may accelerate its growth in Europe.

Blockchain Registration

QR Code for Blockchain Registration